Milbank LLP advised the lead arrangers in connection with the refinancing of a portion of Elanco Animal Health Incorporated’s (NYSE: ELAN) (“Elanco”) outstanding term loans by obtaining, among other things, new US dollar-denominated senior secured term loans in an aggregate principal amount equal to $1.1 billion and a new tranche of euro-denominated senior secured term loans in an aggregate principal amount of €400 million.
Elanco is a global leader in animal health, delivering products and services to prevent and treat disease in farm animals and pets.
The Milbank team was led by New York Global Leveraged Finance partner Lauren Hanrahan, together with associates Julia Wennberg, Angelica Body-Lawson, Anderson Westerman, Mark Freeman and law clerk Eric Yang.
Milbank previously advised the arrangers on the approximately $5 billion financing of Elanco’s acquisition of Bayer AG’s animal health business and on the maturity extension of Elanco’s $750 million revolving credit facility.
